Jiangsu GDK Biotechnology Co Ltd (688670) — Cash Flow-to-Debt Ratio
Jiangsu GDK Biotechnology Co Ltd (688670) has a Cash Flow-to-Debt Ratio of -0.51x as of December 2024, meaning its operating cash flow of CN¥-131.39 Million could theoretically repay -1% of its total liabilities (CN¥255.33 Million) in one year. See 688670 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jiangsu GDK Biotechnology Co Ltd Cash Flow-to-Debt Ratio (2017–2024)
Historical debt coverage capacity for Jiangsu GDK Biotechnology Co Ltd across 8 annual periods. Also explore net asset momentum of Jiangsu GDK Biotechnology Co Ltd to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Jiangsu GDK Biotechnology Co Ltd (2017–2024)
Year-by-year debt coverage analysis for Jiangsu GDK Biotechnology Co Ltd. For market capitalisation and broader financial context, see 688670 company net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.51x | CN¥-131.39 Million | CN¥255.33 Million | ▼ -265.7% |
| 2023 | 0.31x | CN¥80.90 Million | CN¥260.52 Million | ▲ +195.4% |
| 2022 | 0.11x | CN¥38.60 Million | CN¥367.11 Million | ▼ -70.3% |
| 2021 | 0.35x | CN¥103.93 Million | CN¥293.12 Million | ▲ +73.5% |
| 2020 | 0.20x | CN¥109.46 Million | CN¥535.47 Million | ▲ +291.2% |
| 2019 | -0.11x | CN¥-54.05 Million | CN¥505.68 Million | ▼ -20.7% |
| 2018 | -0.09x | CN¥-35.48 Million | CN¥400.73 Million | ▲ +4.3% |
| 2017 | -0.09x | CN¥-33.24 Million | CN¥359.39 Million | — |